Evidence for binding of in vitro glycated low-density lipoproteins by fructosyllysine-specific sites on macrophages and U937 monocyte-like cells

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue 5, 1997, Pages 263-270

  Krantz, S ^a,b   Michalke, M ^a   Brandt, R ^a   Salazar, R ^a   Hartmann, K ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Fructosyllysine; Glycated low density lipoproteins (LDL); Macrophage; Monocyte like cell; Receptor

Indexed keywords

GLYCOSYLATED ALBUMIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER;

ANIMAL CELL; ARTERIOSCLEROSIS; ARTICLE; BINDING COMPETITION; BINDING KINETICS; BINDING SITE; CONTROLLED STUDY; DIABETES MELLITUS; GLYCATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SCATCHARD PLOT;

EID: 0030659596     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211763     Document Type: Article

References (47)

1. Aviram A: Low-density lipoprotein and scavenger receptor activities are modulated by secretory products derived from cells of the arterial wall. Metabolism 38:445-449, 1989
2. Basu SK, Goldstein JL, Anderson RG, Brown MS: Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblast. Proc Natl Acad Sci USA 73: 3178-3182, 1976
3. Bitensky MW, Kowluru A, Kowluru RA: Non-enzymatic glycation and protein recognition. Progr Clin Biol Res 304: 185-203, 1989
4. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254, 1976
5. Brandt R, Landmesser C, Vogt L, Hehmke B, Hanschke R, Kasbohm J, Hartmann K, Jäger B, Krantz S, Michaelis D: Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance. Diabetologia 39: 1140-1147, 1996
6. Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 52: 223-261, 1983
7. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H: Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 91: 9441-9445, 1994
8. Bucala R, Mitchell R, Arnold K, Innerarity T, Vlassara H, Cerami A: Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor. J Biol Chem 270: 10828-10832, 1995
9. Curtiss LK, Witztum JL: Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 34: 452-461, 1985
10. Dyer DG, Blackledge JA, Katz BM, Hull CJ, Adkisson HD, Thorpe SR, Lyons TJ, Baynes JW: The Maillard reaction in vivo. Z Ernährungswiss 30: 29-45, 1991
11. Finot PA, Mauron J: Le blockage de la lysine par la reaction de Maillard. I. Synthese de N-(desoxy-1-D-fructosyl-1)- et N-(desoxy-1-D-lactosyl)-L-lysine. Helv Chim Acta 52: 1488-1495, 1969
12. Flückiger R, Gallop PM: Measurement of nonenzymatic protein glycosylation. Methods Enzvmol 106: 77-87, 1984
13. Gonen B, Baenziger J, Schonfeld G, Jacobsen D, Farrar P: Nonenzymatic glycosylation of proteins: possible relevance to microangiopathy. Diabetes 30: 875-878, 1981
14. Gugliucci A, Siffert J-C, Dumont S, Stahl AJC: Comparative interaction of glycated and oxidized low density lipoproteins with human monocyte-derived macrophages. Int J Immunopathol Pharmacol 5: 51-57, 1993
15. Gugliucci Creriche A, Dumont S, Siffert JC, Stahl AJC: In vitro glycated low-density lipoprotein interaction with human monocyte-derived macrophages. Res Immunol 143: 17-23, 1992
16. Gupta S, Reifici V, Crowley S, Brownlee M, Shan S, Schlondorff D: Interactions of LDL and modified IDL with mesangial cells and matrix. Kidney Int 41: 1161-1169, 1992
17. Hunt JV, Skamarauskas JT, Mitchinson MJ: Protein glycation and fluorescent material in human atheroma. Atherosclerosis 111: 255-265, 1994
18. Klein RL, Lyons TJ, Lopes-Virella MF: Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages. Diabetologia 33: 299-305, 1990
19. Kortlandt W, van Rijn HJM, Erkelens DW: Glycation and lipoproteins. Diab Nutr Metab 6: 231-239, 1993
20. Krantz S, Brandt R, Gromoll B: Binding sites for short-term glycated albumin on peritoneal cells of the rat. Biochim Biophys Acta 1177: 15-24, 1993
21. Krantz S, Gromoll B, von Woedtke G, Lober M: Interaction of glycated albumin with cells of the reticuloendothelial system. Diabetes 40, (suppl 1): 124 A, 1991
22. Krantz S, Salazar R, Brandt R, Kellermann J, Lottspeich F: Purification and partial amino acid sequencing of a fructosyllysine-specific binding protein from cell membranes of the monocyte-like cell line U937. Biochim Biophys Acta 1266: 109-112, 1995
23. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL: Glycosylation of low-density lipoproteins enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37: 550-557, 1988
24. Lorenzi M, Cagliero E, Markey B, Henriksen T, Witztum JL, Sampietro JL: Interaction of human endothelial cells with elevated glucose concentrations and native and glycosylated low density lipoproteins. Diabetologia 26: 218-222, 1984
25. Lyons TJ: Lipoprotein glycation and its metabolic consequences. Diabetes 42, (suppl 2): 67-73, 1992
26. McCohaney PJ, Dixon FJ: A method for trace iodination of proteins for immunological studies. Int Arch Allergy 29: 185-189, 1966
27. Mills GL, Lane PA, Weech PK: Laboratory techniques in biochemistry and molecular biology. Vol. 14, pp 1-507, Elsevier Amsterdam, New York, Oxford, 1992
28. Salazar R, Brandt R, Krantz S: Expression of fructosyllysine receptors on human monocytes and monocyte-like cell lines. Biochim Biophys Acta 1266: 57-63, 1995
29. Sasaki J, Cottam GL: Glycosylation of human LDL and its metabolism in human skin fibroblasts. Biochem Biophys Res Commun 104: 977-983, 1982
30. Schleicher E: Glykierung von Proteinen: Pathobiochemische und diagnostische Aspekte. Lab med 17: 381-387, 1993
31. Schleicher E, Deufel T, Wieland OH: Non-enzymatic glycosylation of human serum lipoproteins. Elevated epsilonlysine glycosylated low-density lipoproteins in diabetic patients. FEBS Lett 129: 1-4, 1981
32. Schleicher E, Olgemüller B, Schün J, Durst T, Wieland OH: Limited nonenzymatic glycosylation of low-density lipoproteins does not alter its catabolism in tissue culture. Biochim Biophys Acta 846: 226-233, 1985
33. Schleicher E, Wieland OH: Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins. J Clin Chem Clin Biochem 19: 81-87, 1981
34. Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier J-L, Ogawa S, Kuwabara K, Matsumoto M, Stern D: A novel cellular receptor for advanced glycation end products. Diabetes 45, (suppl 3): S77-S80, 1996
35. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Wang F, Pan Y-CE, Tsang TL, Stern D: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial surface. J Biol Chem 267: 14987-14997, 1992
36. Semenkovich CF, Ostlund RE, Olson MOJ, Yang JW: A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry 29: 9708-9713, 1990
37. Shaklai N, Garlick RL, Bunn HF: Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 259: 3812-3817, 1984
38. Steinbrecher UP, Witztum JL: Glycosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slow their catabolism. Diabetes 33: 130-134, 1984
39. Triau JE, Arbetter J, Schaefer EJ: Impaired hepatocyte binding, uptake and degradation of glucosylated low-density lipoproteins. Biochim Biophys Acta 877: 359-365, 1986
40. Via DP, Dresel HA, Gotto AM: Isolation and assay of the Ac-LDL receptor. Methods Enzymol 109: 216-226, 1986
41. Vlassara H: Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues. Diabetes 41, (suppl 2): 52-56, 1992
42. Vlassara H, Li YM, Imani F, Woiciechowski D, Yang Z, Liu F-T, Cerami A: Identification of galectin-3 as a high affinity binding protein for advanced glycation end products (AGE): A new member of the AGE-receptor complex. Molecular Medicine 1: 634-646, 1995
43. Wallin B, Rosengren B, Shertzer HG, Camejo G: Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate. Anal Biochem 208: 10-15, 1993
44. Wolff SP, Bascal ZA, Hunt VJ: "Autoxidative glycosylation": free radicals and glycation theory. Progr Clin Biol Res 304: 259-275, 1989
45. Wu V-Y, Cohen MP: Evidence for ligand receptor system mediating the biologic effects of glycated albumin in glomerular mesangial cells. Biochem Biophys Res Commun 207: 521-528, 1995
46. Wu V-Y, Cohen MP: Identification of aortic endothelial cell binding proteins for Amadori adducts in glycated albumin. Biochem Biophys Res Commun 193: 1131-1136, 1993
47. Wu V-Y, Cohen MP: Receptor specific for Amadori-modified glycated albumin on murine endothelial cells. Biochem Biophys Res Commun 198: 734-739, 1994